IL-12 enhances CTL synapse formation and induces self-reactivity

Journal of Immunology

Volumn 182, Issue 3, 2009, Pages 1351-1361

  Markiewicz, Mary A ^a   Wise, Erica L ^a   Buchwald, Zachary S ^a   Cheney, Elizabeth E ^a   Hansen, Ted H ^a   Suri, Anish ^a   Cemerski, Saso ^a   Allen, Paul M ^a   Shaw, Andrey S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 12; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; T LYMPHOCYTE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA; AUTACOID; AUTOANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; BINDING AFFINITY; CYTOTOXIC T LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; AMINO ACID SEQUENCE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; CYTOTOXICITY; IMMUNOLOGICAL SYNAPSE; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; TRANSGENIC MOUSE;

AMINO ACID SEQUENCE; ANIMALS; AUTOANTIGENS; CELLS, CULTURED; CYTOTOXICITY, IMMUNOLOGIC; IMMUNOLOGICAL SYNAPSES; INFLAMMATION MEDIATORS; INTERLEUKIN-12; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, CYTOTOXIC;

EID: 63149144037     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.3.1351     Document Type: Article

References (54)

1. Hemmer, B., B. T. Fleckenstein, M. Vergelli, G. Jung, H. McFarland, R. Martin, and K. H. Wiesmuller. 1997. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J. Exp. Med. 185: 1651-1659.
2. Hemmer, B., B. Gran, Y. Zhao, A. Marques, J. Pascal, A. Tzou, T. Kondo, I. Cortese, B. Bielekova, S. E. Straus, et al. 1999. Identification of candidate T-cell epitopes and molecular mimics in chronic Lyme disease. Nat. Med. 5: 1375-1382.
3. Hemmer, B., C. Pinilla, J. Appel, J. Pascal, R. Houghten, and R. Martin. 1998. The use of soluble synthetic peptide combinatorial libraries to determine antigen recognition of T cells. J. Pept. Res. 52: 338-345.
4. Mason, D. 1998. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol. Today 19: 395-404.
5. Kersh, G. J., and P. M. Allen. 1996. Essential flexibility in the T-cell recognition of antigen. Nature 380: 495-498.
6. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signaling: altered phospho-ζ and lack of ZAP70 recruitment in APL-induced T cell anergy. Cell 79: 913-922.
7. Barton, G. M., and A. Y. Rudensky. 1999. Evaluating peptide repertoires within the context of thymocyte development. Semin. Immunol. 11: 417-422.
8. Mahajan, V. S., I. B. Leskov, and J. Z. Chen. 2005. Homeostasis of T cell diversity. Cell. Mol. Immunol. 2: 1-10.
9. Davis, M. M., M. Krogsgaard, M. Huse, J. Huppa, B. F. Lillemeier, and Q. J. Li. 2007. T cells as a self-referential, sensory organ. Annu. Rev. Immunol. 25: 681-695.
10. Krogsgaard, M., Q. J. Li, C. Sumen, J. B. Huppa, M. Huse, and M. M. Davis. 2005. Agonist/endogenous peptide-MHC heterodimers drive T cell activation and sensitivity. Nature 434: 238-243.
11. Lee, K. H., A. R. Dinner, C. Tu, G. Campi, S. Raychaudhuri, R. Varma, T. N. Sims, W. R. Burack, H. Wu, J. Wang, et al. 2003. The immunological synapse balances T cell receptor signaling and degradation. Science 302: 1218-1222.
12. Grakoui, A., S. K. Bromley, C. Sumen, M. M. Davis, A. S. Shaw, P. M. Allen, and M. L. Dustin. 1999. The immunological synapse: a molecular machine controlling T cell activation. Science 285: 221-227.
13. Krummel, M. F., and M. M. Davis. 2002. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 14: 66-74.
14. Monks, C. R., B. A. Freiberg, H. Kupfer, N. Sciaky, and A. Kupfer. 1998. Three-dimensional segregation of supramolecular activation clusters in T cells. Nature 395: 82-86.
15. Cemerski, S., J. Das, J. Locasale, P. Arnold, E. Giurisato, M. A. Markiewicz, D. Fremont, P. M. Allen, A. K. Chakraborty, and A. S. Shaw. 2007. The stimulatory potency of T cell antigens is influenced by the formation of the immunological synapse. Immunity 26: 345-355.
16. + CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol. 175: 2825-2833.
17. Hogquist, K. A., S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone. 1994. T cell receptor antagonist peptides induce positive selection. Cell 76: 17-27.
18. + T cell adoptive immunotherapy. Immunity 13: 265-276.
19. d of normal and TAP-deficient cells. Eur. J. Immunol. 36: 544-557.
20. Morita, S., T. Kojima, and T. Kitamura. 2000. Plat-E: an efficient and stable system for transient packaging of retroviruses. Gene Ther. 7: 1063-1066.
21. Onishi, M., S. Kinoshita, Y. Morikawa, A. Shibuya, J. Phillips, L. L. Lanier, D. M. Gorman, G. P. Nolan, A. Miyajima, and T. Kitamura. 1996. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24: 324-329.
22. Li, C., and W. H. Wong. 2001. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc. Natl. Acad. Sci. USA 98: 31-36.
23. Townsend, A., C. Ohlen, L. Foster, J. Bastin, H. G. Ljunggren, and K. Karre. 1989. A mutant cell in which association of class I heavy and light chains is induced by viral peptides. Cold Spring Harbor Symp. Quant. Biol. 54(Pt. 1): 299-308.
24. Van Bleek, G. M., and S. G. Nathenson. 1990. Isolation of an endogenously processed immunodominant viral peptide from the class I H-2Kb molecule. Nature 348: 213-216.
25. Alam, S. M., G. M. Davies, C. M. Lin, T. Zal, W. Nasholds, S. C. Jameson, K. A. Hogquist, N. R. Gascoigne, and P. J. Travers. 1999. Qualitative and quantitative differences in T cell receptor binding of agonist and antagonist ligands. Immunity 10: 227-237.
26. Alam, S. M., P. J. Travers, J. L. Wung, W. Nasholds, S. Redpath, S. C. Jameson, and N. R. Gascoigne. 1996. T-cell-receptor affinity and thymocyte positive selection. Nature 381: 616-620.
27. Gascoigne, N. R., T. Zal, and S. M. Alam. 2001. T-cell receptor binding kinetics in T-cell development and activation. Expert Rev. Mol. Med. 2001: 1-17.
28. Santori, F. R., W. C. Kieper, S. M. Brown, Y. Lu, T. A. Neubert, K. L. Johnson, S. Naylor, S. Vukmanovic, K. A. Hogquist, and S. C. Jameson. 2002. Rare, structurally homologous self-peptides promote thymocyte positive selection. Immunity 17: 131-142.
29. Salter, R. D., and P. Cresswell. 1986. Impaired assembly and transport of HLA-A and -B antigens in a mutant TXB cell hybrid. EMBO J. 5: 943-949.
30. Ikeda, H., N. Ohta, K. Furukawa, H. Miyazaki, L. Wang, K. Kuribayashi, L. J. Old, and H. Shiku. 1997. Mutated mitogen-activated protein kinase: a tumor rejection antigen of mouse sarcoma. Proc. Natl. Acad. Sci. USA 94: 6375-6379.
31. Lebedeva, T., M. L. Dustin, and Y. Sykulev. 2005. ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr. Opin. Immunol. 17: 251-258.
32. Somersalo, K., N. Anikeeva, T. N. Sims, V. K. Thomas, R. K. Strong, T. Spies, T. Lebedeva, Y. Sykulev, and M. L. Dustin. 2004. Cytotoxic T lymphocytes form an antigen-independent ring junction. J. Clin. Invest. 113: 49-57.
33. Gaglia, J. L., E. A. Greenfield, A. Mattoo, A. H. Sharpe, G. J. Freeman, and V. K. Kuchroo. 2000. Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells. J. Immunol. 165: 6091-6098.
34. Smith, A., P. Stanley, K. Jones, L. Svensson, A. McDowall, and N. Hogg. 2007. The role of the integrin LFA-1 in T-lymphocyte migration. Immunol. Rev. 218: 135-146.
35. Trinchieri, G., M. Wysocka, A. D'Andrea, M. Rengaraju, M. Aste-Amezaga, M. Kubin, N. M. Valiante, and J. Chehimi. 1992. Natural killer cell stimulatory factor (NKSF) or interleukin-12 is a key regulator of immune response and inflammation. Prog. Growth Factor Res. 4: 355-368.
36. + immunoregulatory T cells. Immunol. Cell Biol. 84: 487-501.
37. Esquerre, M., B. Tauzin, M. Guiraud, S. Muller, A. Saoudi, and S. Valitutti. 2008. Human regulatory T cells inhibit polarization of T helper cells toward antigen-presenting cells via a TGF-β-dependent mechanism. Proc. Natl. Acad. Sci. USA 105: 2550-2555.
38. Bromley, S. K., and M. L. Dustin. 2002. Stimulation of naive T-cell adhesion and immunological synapse formation by chemokine-dependent and -independent mechanisms. Immunology 106: 289-298.
39. Carrasco, Y. R., S. J. Fleire, T. Cameron, M. L. Dustin, and F. D. Batista. 2004. LFA-1/ICAM-1 interaction lowers the threshold of B cell activation by facilitating B cell adhesion and synapse formation. Immunity 20: 589-599.
40. Beal, A. M., N. Anikeeva, R. Varma, T. O. Cameron, P. J. Norris, M. L. Dustin, and Y. Sykulev. 2008. Protein kinase Cθ regulates stability of the peripheral adhesion ring junction and contributes to the sensitivity of target cell lysis by CTL. J. Immunol. 181: 4815-4824.
41. Suzuki, J., S. Yamasaki, J. Wu, G. A. Koretzky, and T. Saito. 2007. The actin cloud induced by LFA-1-mediated outside-in signals lowers the threshold for T-cell activation. Blood 109: 168-175.
42. Wiedemann, A., D. Depoil, M. Faroudi, and S. Valitutti. 2006. Cytotoxic T lymphocytes kill multiple targets simultaneously via spatiotemporal uncoupling of lytic and stimulatory synapses. Proc. Natl. Acad. Sci. USA 103: 10985-10990.
43. Cemerski, S., J. Das, E. Giurisato, M. A. Markiewicz, P. M. Allen, A. K. Chakraborty, and A. S. Shaw. 2008. The balance between T cell receptor signaling and degradation at the center of the immunological synapse is determined by antigen quality. Immunity 29: 414-422.
44. Li, Q., J. J. Chau, P. J. Ebert, G. Sylvester, H. Min, G. Liu, R. Braich, M. Manoharan, J. Soutschek, P. Scare, et al. 2007. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell 129: 147-161.
45. Trinchieri, G. 2003. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 3: 133-146.
46. + T cells. Immunol. Rev. 211: 81-92.
47. Colombo, M. P., and G. Trinchieri. 2002. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 13: 155-168.
48. Kang, B. Y., and T. S. Kim. 2006. Targeting cytokines of the interleukin-12 family in autoimmunity. Curr. Med. Chem. 13: 1149-1156.
49. Del Vecchio, M., E. Bajetta, S. Canova, M. T. Lotze, A. Wesa, G. Parmiani, and A. Anichini. 2007. Interleukin-12: biological properties and clinical application. Clin. Cancer Res. 13: 4677-4685.
50. Peterson, A. C., H. Harlin, and T. F. Gajewski. 2003. Immunization with Melan-A peptide-pulsed peripheral blood mononuclear cells plus recombinant human interleukin-12 induces clinical activity and T-cell responses in advanced melanoma. J. Clin. Oncol. 21: 2342-2348.
51. Fallarino, F., C. Uyttenhove, T. Boon, and T. F. Gajewski. 1999. Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12. Int. J. Cancer 80: 324-333.
52. Cebon, J., E. Jager, M. J. Shackleton, P. Gibbs, I. D. Davis, W. Hopkins, S. Gibbs, Q. Chen, J. Karbach, H. Jackson, et al. 2003. Two phase I studies of low dose recombinant human IL-12 with Melan-A and influenza peptides in subjects with advanced malignant melanoma. Cancer Immun. 3: 7.
53. Lee, P., F. Wang, J. Kuniyoshi, V. Rubio, T. Stuges, S. Groshen, C. Gee, R. Lau, G. Jeffery, K. Margolin, et al. 2001. Effects of interleukin-12 on the immune response to a multipeptide vaccine for resected metastatic melanoma. J. Clin. Oncol. 19: 3836-3847.
54. Libbey, J. E., L. L. McCoy, and R. S. Fujinami. 2007. Molecular mimicry in multiple sclerosis. Int. Rev. Neurobiol. 79: 127-147.